|
1
|
Deveraux QL, Takahashi R, Salvesen GS and
Reed JC: X-linked IAP is a direct inhibitor of cell-death
proteases. Nature. 388:300–304. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Srinivasula SM, Hegde R, Saleh A, Datta P,
Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y
and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and
Smac/DIABLO regulates caspase activity and apoptosis. Nature.
410:112–116. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liston P, Fong WG, Kelly NL, Toji S,
Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW and Korneluk
RG: Identification of XAF1 as an antagonist of XIAP anti-Caspase
activity. Nat Cell Biol. 3:128–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fong WG, Liston P, Rajcan-Separovic E, St
Jean M, Craig C and Korneluk RG: Expression and genetic analysis of
XIAP-associated factor 1 (XAF1) in cancer cell lines. 70:113–122.
2000.
|
|
5
|
Xing Z, Yu R, Li S and Liu Z: Regulatory
effects of somatostatin on XAF1 in prostate cancer. Regul Peptides.
164:472010. View Article : Google Scholar
|
|
6
|
Kempkensteffen C, Fritzsche FR, Johannsen
M, Weikert S, Hinz S, Dietel M, Riener MO, Moch H, Jung K, Krause
H, et al: Down-regulation of the pro-apoptotic XIAP associated
factor-1 (XAF1) during progression of clear-cell renal cancer. BMC
Cancer. 9:2762009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leaman DW, Chawla-Sarkar M, Vyas K,
Reheman M, Tamai K, Toji S and Borden EC: Identification of
X-linked inhibitor of apoptosis-associated factor-1 as an
interferon-stimulated gene that augments TRAIL Apo2L-induced
apoptosis. J Biol Chem. 277:28504–28511. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tu SP, Sun YW, Cui JT, Zou B, Lin MC, Gu
Q, Jiang SH, Kung HF, Korneluk RG and Wong BC: Tumor Suppressor
XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis
factor-related apoptosis-inducing ligand to suppress colon cancer
growth and trigger tumor regression. Cancer. 116:1252–1263. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ju WC, Huang GB, Luo XY, Ren WH, Zheng DQ,
Chen PJ, Lou YF and Li B: X-linked inhibitor of
apoptosis-associated factor l (XAFl) enhances the sensitivity of
colorectal cancer cells to cisplatin. Med Oncol. 31:2732014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma B and Wang Y, Zhou X, Huang P, Zhang R,
Liu T, Cui C, Liu X and Wang Y: Synergistic suppression effect on
tumor growth of hepatocellular carcinoma by combining oncolytic
adenovirus carrying XAF1 with cisplatin. J Cancer Res Clin Oncol.
141:419–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiao L, Gu Q, Dai Y, Shen Z, Liu X, Qi R,
Ma J, Zou B, Li Z, Lan HY and Wong BC: XIAP-associated factor 1
(XAF1) suppresses angiogenesis in mouse endothelial cells. Tumour
Biol. 29:122–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu LM, Shi DM, Dai Q, Cheng XJ, Yao WY,
Sun PH, Ding Y, Qiao MM, Wu YL, Jiang SH and Tu SP: Tumor
suppressor XAF1 induces apoptosis, inhibits angiogenesis and
inhibits tumor growth in hepatocellular carcinoma. Oncotarget.
5:5403–5415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang J, Li Y, Qi Y, Zhang Y, Zhang L,
Wang Z, Zhang X and Gui L: Coordinated regulation of autophagy and
apoptosis determines endothelial cell fate during Dengue virus type
2 infection. Mol Cell Biochem. 397:157–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Folberg R and Maniotis AJ: Vasculogenic
mimicry. APMISAPMIS. 112:508–525. 2004. View Article : Google Scholar
|
|
16
|
Gao Y, Zhao X, Gu Q, Wang JY, Zhang SW,
Zhang DF, Wang XH, Zhao N, Gao YT and Sun BC: Correlation of
vasculogenic mimicry with clinicopathologic features and prognosis
of ovarian carcinoma. Zhonghua Bing Li Xue Za Zhi. 38:585–589.
2009.(In Chinese). PubMed/NCBI
|
|
17
|
Tang HS, Feng YJ and Yao L: Angiogenesis,
vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J
Gynecol Cancer. 19:605–610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vartanian AA, Burova OS, Stepanova EV and
Baryshnikov AY: The involvement of apoptosis in melanoma
vasculogenic mimicry. Melanoma Res. 17:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Mao H, Hao Q, Wang Y, Yang Y, Shen
L, Huang S and Liu P: Association of expression of XIAP-associated
factor 1 (XAF1) with clinicopathologic factors, overall survival,
microvessel density and cisplatin-resistance in ovarian cancer.
Regul Pept. 178:36–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao ZS, Chu YQ, Ye ZY, Wang YY and Tao
HQ: Overexpression of matrix metalloproteinase 11 in human gastric
carcinoma and its clinicopathologic significance. Hum Pathol.
41:686–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sood AK, Seftor EA, Fletcher MS, Gardner
LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular
determinants of ovarian cancer plasticity. Am J Pathol.
158:1279–1288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naito S, von Eschenbach AC, Giavazzi R and
Fidler IJ: Growth and metastasis of tumor cells isolated from a
human renal cell carcinoma implanted into different organs of nude
mice. Cancer Res. 46:4109–4115. 1986.PubMed/NCBI
|
|
23
|
Baeten CI, Hillen F, Pauwels P, de Bruine
AP and Baeten CG: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K,
Pang JC, Ng HK and Chen ZP: Clinical significance of vasculogenic
mimicry in human gliomas. J Neurooncol. 105:173–179. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shirakawa K, Wakasugi H, Heike Y, Watanabe
I, Yamada S, Saito K and Konishi F: Vasculogenic mimicry and
pseudo-comedo formation in breast cancer. Int J Cancer. 99:821–828.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu P, Ning Y, Yao L, Chen M and Xu C: The
proliferation, apoptosis, invasion of endothelial-like epithelial
ovarian cancer cells induced by hypoxia. J Exp Clin Cancer Res.
29:1242010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ,
Huang Y, Zhao YQ and Jiang H: Plasticity of ovarian cancer cell
SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer.
18:476–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sood AK, Fletcher MS, Zahn CM, Gruman LM,
Coffin JE, Seftor EA and Hendrix MJ: The clinical significance of
tumor cell-lined vasculature in ovarian carcinoma: Implications for
anti-vasculogenic therapy. Cancer Biol Ther. 1:661–664. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ling ZQ, Lv P, Lu XX, Yu JL, Han J, Ying
LS, Zhu X, Zhu WY, Fang XH, Wang S and Wu YC: Circulating
methylated XAF1 DNA indicates poor prognosis for gastric cancer.
PLoS One. 8:e671952013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim SK, Park HJ, Seok H, Jeon HS, Kim JW,
Chung JH, Kwon KH, Woo SH, Lee BW and Baik HH: Missense
polymorphisms in XIAP-associated factor-1 (XAF1) and risk of
papillary thyroid cancer: Correlation with clinicopathological
features. Anticancer Res. 33:2205–2210. 2013.PubMed/NCBI
|
|
32
|
Huang J, Yao W, Zhu Q, Tu SP, Yuan F, Wang
HF, Zhang YP and Yuan YZ: XAF1 as a prognostic biomarker and
therapeutic target in pancreatic cancer. Cancer Sci. 101:559–567.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mei J, Gao Y, Zhang L, Cai X, Qian Z,
Huang H and Huang W: VEGF-siRNA silencing induces apoptosis,
inhibits proliferation and suppresses vasculogenic mimicry in
osteosarcoma in vitro. Exp Oncol. 30:29–34. 2008.PubMed/NCBI
|
